Thursday, February 14, 2013

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 ...
Daily Markets (press release)
WEIFANG, SHANDONG, China, Feb. 14, 2013 /PRNewswire/ — Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company" or "We" or "Us" or "Our"), a manufacturer and distributor in China of glucose and starch as pharmaceutical ...
See all stories on this topic »

Daily Markets (press release)
'Numb3rs' CBS takes on pharmaceutical company after drug deaths
Examiner.com
The 2nd re-run episode at 8 p.m. Wednesday Feb. 13, 2013 was called "Toxin." The 'My50-TV' synopsis is right here - "A few apparently random cases of product tampering lead to a mountain man with a grudge - a pharmaceutical company and a conspiracy.
See all stories on this topic »

Examiner.com
Leading Pharmaceutical Companies Mid-day Trading with Mixed Results and ...
MarketWatch (press release)
CORAL SPRINGS, Florida, February 14, 2013 /PRNewswire via COMTEX/ -- FinancialNewsMedia.com reports on active HealthCare Companies experiencing mid-day trading today with mixed results: Crown Marketing Pharmaceutical, Abbott Laboratories ...
See all stories on this topic »
New Market Report: Taisho Pharmaceutical Co., Ltd. - Product Pipeline Review ...
SBWire (press release)
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Taisho Pharmaceutical Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from Taisho ...
See all stories on this topic »
Tianyin Pharmaceutical's CFO Discusses F2Q 2013 Results - Earnings Call ...
Seeking Alpha
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Tianyin Pharmaceutical, Inc. F2Q 2013 Earnings Conference Call. (Operator instructions.) And as a reminder this call is being recorded today, February 14, 2013. I would ...
See all stories on this topic »
"Patent cliff" threatens profitability of pharmaceutical industry
Manufacturers' Monthly
Big Australian pharmaceutical companies are exposed to a "patent cliff", according to a new PriceWaterhouseCoopers report. According to PWC research, patent expirations will strip $148 billion out of the top 500 pharmaceutical companies' earnings over ...
See all stories on this topic »
Study: Fish in pharmaceutical-tainted water suffer reaction
Kennebec Journal
Researchers around the world have been taking a close look at the effects of pharmaceuticals in extremely low concentrations, measured in parts per billion. Such drugs have turned up in waterways in Europe, the U.S. and elsewhere over the past decade.
See all stories on this topic »
Pharmaceutical Distribution Security Alliance Applauds IOM Call for a National ...
PharmaLive (press release) (subscription)
"The Pharmaceutical Distribution Security Alliance (PDSA) applauds the Institute of Medicine (IOM) for recognizing that new legislation is needed to protect all Americans from the threat of counterfeit drugs. PDSA is particularly pleased that the IOM ...
See all stories on this topic »
Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for ...
NASDAQ
Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex-dividend on February 19, 2013. A cash dividend payment of $0.31 per share is scheduled to be paid on March 07, 2013. Shareholders who purchased TEVA stock prior to the ex-dividend ...
See all stories on this topic »
Pharmaceutical Market Research - Leger acquires Toronto-based firm ...
Canada NewsWire (press release)
MONTREAL, Feb. 14, 2013 /CNW Telbec/ - Leger - The Research Intelligence Group is pleased to announce its recent acquisition of Researchology, a Toronto market research firm specializing in the pharmaceutical sector. Researchology is recognized for ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

1 comments:

Unknown said...

We do consultancy service for FDA License and FDA compliance and Regulatory etc , Our consultancy network of Mumbai, Thane , Navimumbai etc for more details contact 9930962213

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost